Probiont is developing cancer-on-a-chip technology that will enable rapid screening of cancer drugs used in immunotherapy for early identification of effective treatments for patients.
| Website | https://probiont.fi/ |
| Employees | 5 (2 on RocketReach) |
| Address | Haartmaninkatu 4, Helsinki, Uusimaa 00290, FI |
| Industry | Biotechnology Research |
| Keywords | Immunotherapy, Cancer Research, Cancer Treatment, Cancer Therapies, Drug Screening, Therapeutic Development, Lab On A Chip, Drug Discovery, Precision Medicine, In Vitro Testing, Drug Development, Personalized Medicine, Cancer Diagnostics, Pharmaceutical Research, Microfluidic Devices, Biotechnology, Medical Technology, Clinical Trials, Biomedical Engineering |
Looking for a particular Probiont employee's phone or email?
Probiont Questions
Benedek Poor is the CEO Founder of Probiont.
2 people are employed at Probiont.
Probiont is based in Helsinki, Uusimaa.
Top Probiont Employees
G2Crowd Trusted
300K+
Plugin Users
